Exelixis
EXEL
#1767
Rank
ยฃ8.45 B
Marketcap
ยฃ31.40
Share price
0.96%
Change (1 day)
15.07%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company